Back

Omega-3 fatty acid supplementation and major cardiovascular events in maintenance haemodialysis: Systematic review and meta-analysis including PISCES

29 August 2026 (16:25 - 16:35)
Organised by: Logo
Congress Presentation Part of: Cardiovascular pharmacotherapy in advanced kidney disease: efficacy, safety, and outcomes Renal Failure and Cardiovascular Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Musab Taha Ahmed Egaimi

Sheikh Khalifa Specialty Hospital ( SKSH ), Ras al Khaimah (United Arab Emirates)

4 More presentations in this session

Presentation thumbnail
Effect of dapagliflozin on left ventricular mass in patients with kidney failure receiving maintenance hemodialysis: Primary results from the DAPA-HD trial
Associate Professor T. Zelniker (Vienna, AT)
Abstract Slides
Presentation thumbnail
Nanoformulated omega-3-rich linseed oil reverses ex vivo the phenotype of monocytes of hemodialysis patients from a pro into an anti-inflammatory one with attenuated ROS formation and cell activation
Doctor G. Lima (Strasbourg, FR)
Abstract Slides
Presentation thumbnail
Analysis of the effect of specific therapy on exercise capacity in patients with anderson-fabry disease
Doctor A. Cuomo (Naples, IT)
Abstract Slides
Presentation thumbnail
Real-world effectiveness and safety of finerenone in patients with chronic kidney disease and type 2 diabetes in the United States: A FOUNTAIN platform analysis
Doctor S. Rao (Durham, US)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular pharmacotherapy in advanced kidney disease: efficacy, safety, and outcomes

The Event

Event poster

ESC Congress 2026

29 August 2026 16:25 CET
You may be interested in
thumbnail
Congress Presentation
Changes in EPA and DHA during supplementation with Omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial
27 August 2021
thumbnail
Congress Presentation
Hepcidin and cardiovascular events in patients with chronic kidney disease undergoing dialysis: a post-hoc analysis of the ASCEND-D trial
1 September 2025
thumbnail
Congress Presentation
Efficacy of inclisiran versus placebo in atherosclerotic cardiovascular disease: A systematic review and meta-analysis
19 February 2026
thumbnail
Congress Presentation
Impact of in-hospital intensification of heart failure medical treatment on clinical outcomes in dialysis-dependent patients with worsening heart failure
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources